This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised)
by Sweta Killa
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
by Zacks Equity Research
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
4 Best Stocks to Buy for Superb Earnings Acceleration
by Tirthankar Chakraborty
Studies have shown that a majority of successful stocks had seen acceleration in earnings before an uptick in the stock price.
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
by Zacks Equity Research
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
Small-Cap ETFs & Stocks to Outperform This Holiday Season
by Sweta Killa
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
5 Stocks With Recent Price Strength to Strengthen Portfolio
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Top Ranked Momentum Stocks to Buy for November 9th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, November 9th
Will Vericel (VCEL) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Vericel (VCEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
by Zacks Equity Research
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
How to Invest in the Hot Medical Device Innovators
by Tracey Ryniec
Forget the biotechs. Medical device companies are innovating in amazing ways. Here's how to invest.
Will Vericel (VCEL) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Vericel Corporation (VCEL).